OZiva Protein & Herbs Women

OZiva Protein & Herbs Women provides a comprehensive amino acid blend with the inclusion of 67.5 g of whey protein, making it suitable for women looking for a protein supplement enriched with essential, semi-essential, and non-essential amino acids. However, the overall quality is dampened by its relatively high cost of ₹132.76 per serving, which is notably 17% above the market category average.

Women who require a transparent protein source may appreciate this product, but they should weigh the price against the benefits. The transparency is unparalleled, but the value proposition remains weak given its average performance in terms of formula and dosing.

The formula includes a range of amino acids: BCAAs (14.25 g), EAAs (30.38 g), SEAAs (10.3 g), and NEAAs (24.57 g), implying a broad-based approach to muscular and overall health support. The primary protein source is whey, which is effective in muscle recovery, but the presence of 4.4 g of sugars and 8.85 g of carbohydrates might not be necessary for all fitness goals.

The inclusion of 67.5 g of whey protein ensures a robust amino acid profile; however, the doses for other components, such as carbohydrates (8.85 g) and total sugars (4.4 g), may not align with the needs of those focusing on a lean diet plan. The amino acid quantities suggest a balanced contribution to muscle recovery, though others aiming for low-calorie intake might find the caloric content excessive.

At ₹132.76 per serving, OZiva Protein & Herbs Women is priced significantly above the category average of ₹113.76 per serving. While the transparency of the label is commendable, the premium price does not necessarily equate to an equally proportionate benefit, making it less attractive on a value-for-money basis.

OZiva excels with a transparency score of 10.0, providing clear and detailed labeling regarding ingredient quantities. The transparent approach confirms no use of proprietary blends, allowing consumers to understand exactly what they are ingesting. However, there is no mention of third-party testing claims.